Tango Therapeutics, Inc. (TNGX)
21.84
-0.06
(-0.25%)
USD |
NASDAQ |
Oct 07, 16:00
21.84
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Net Income (Quarterly) : -55.34M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.34M |
| March 31, 2026 | -45.51M |
| December 31, 2025 | -38.75M |
| September 30, 2025 | 15.88M |
| June 30, 2025 | -38.85M |
| March 31, 2025 | -39.88M |
| December 31, 2024 | -37.67M |
| September 30, 2024 | -29.17M |
| June 30, 2024 | -25.55M |
| March 31, 2024 | -37.91M |
| December 31, 2023 | -30.76M |
| September 30, 2023 | -22.26M |
| June 30, 2023 | -20.71M |
| Date | Value |
|---|---|
| March 31, 2023 | -28.01M |
| December 31, 2022 | -29.06M |
| September 30, 2022 | -29.05M |
| June 30, 2022 | -24.86M |
| March 31, 2022 | -25.21M |
| December 31, 2021 | -22.05M |
| September 30, 2021 | -19.59M |
| June 30, 2021 | -4.493M |
| March 31, 2021 | -12.11M |
| December 31, 2020 | -8.864M |
| September 30, 2020 | -26.80M |
| June 30, 2020 | -0.0005M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -122.68M |
| NovelStem International Corp. | -0.0858M |
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Summit Therapeutics, Inc. | -215.70M |
| Kezar Life Sciences, Inc. | -5.756M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 55.34M |
| EPS Diluted (Quarterly) | -0.3692 |
| Enterprise Value | 2.706B |
| Earnings Yield | -3.83% |
| Normalized Earnings Yield | -3.834 |